NADAC acquisition cost data for INSULIN ASPART 100 UNIT/ML VL. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 73070010011 | $13.87 | 2022-12-21 | Rx |
| 73070010011 | $13.87 | 2022-12-21 | Rx |
Generic: Insulin Aspart | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | $11.8M | 53,350 | 24,803 | $14.70 |
| 2021 | $19.8M | 69,829 | 28,795 | $14.68 |
| 2022 | $17.1M | 60,991 | 25,210 | $14.90 |
| 2023 | $16.8M | 58,892 | 25,052 | $15.00 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Florida | $1.7M | 6,524 | 2,383 |
| Pennsylvania | $1.4M | 4,161 | 1,565 |
| California | $974.2K | 3,883 | 1,662 |
| Kentucky | $882.7K | 1,992 | 764 |
| Texas | $852.1K | 3,680 | 1,724 |
| New York | $708.9K | 2,217 | 1,016 |
| Illinois | $687.2K | 2,802 | 1,237 |
| Ohio | $658.1K | 2,319 | 1,065 |
| North Carolina | $616.6K | 1,433 | 650 |
| Wisconsin | $575.9K | 1,575 | 561 |
| Minnesota | $547.2K | 1,377 | 452 |
| Michigan | $494.3K | 2,078 | 1,007 |
| Missouri | $490.3K | 1,838 | 719 |
| Georgia | $443.6K | 2,063 | 1,101 |
| Tennessee | $406.9K | 1,553 | 671 |
| Oregon | $405.4K | 1,154 | 434 |
| West Virginia | $370.5K | 880 | 374 |
| Alabama | $353.6K | 1,399 | 558 |
| Virginia | $345.9K | 1,085 | 473 |
| Mississippi | $318.6K | 1,706 | 620 |
| Indiana | $317.1K | 1,220 | 565 |
| Arkansas | $264.0K | 1,411 | 507 |
| Washington | $247.4K | 702 | 338 |
| Iowa | $229.8K | 999 | 422 |
| Idaho | $224.6K | 489 | 175 |
| New Jersey | $212.2K | 1,000 | 519 |
| Louisiana | $203.7K | 876 | 409 |
| Arizona | $194.5K | 649 | 376 |
| Massachusetts | $179.6K | 775 | 403 |
| Maryland | $170.4K | 602 | 299 |
| Utah | $145.7K | 353 | 190 |
| Connecticut | $127.4K | 423 | 200 |
| Oklahoma | $124.9K | 603 | 311 |
| Colorado | $114.8K | 398 | 186 |
| Kansas | $104.4K | 392 | 204 |
| South Carolina | $94.4K | 292 | 163 |
| Maine | $86.9K | 203 | 115 |
| Nebraska | $71.3K | 266 | 140 |
| New Mexico | $69.0K | 208 | 124 |
| Nevada | $57.1K | 184 | 99 |
| New Hampshire | $56.4K | 177 | 98 |
| North Dakota | $50.4K | 100 | 53 |
| Montana | $47.1K | 113 | 56 |
| South Dakota | $44.4K | 114 | 52 |
| Delaware | $35.9K | 111 | 61 |
| Vermont | $30.3K | 77 | 33 |
| Hawaii | $25.2K | 64 | 37 |
| Rhode Island | $24.7K | 94 | 46 |
| District of Columbia | $17.6K | 89 | 45 |
| Armed Forces Pacific | $14.1K | 17 | N/A |
| Wyoming | $11.0K | 54 | 28 |
| Puerto Rico | $9.3K | 55 | 22 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.